Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04006522
Recruitment Status : Recruiting
First Posted : July 5, 2019
Last Update Posted : October 5, 2020
Sponsor:
Information provided by (Responsible Party):
Orhan Kemal Oz, University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 15, 2024
Estimated Study Completion Date : July 15, 2025